Endurance Wealth Management’s Moderna MRNA Stock Holding History

Endurance Wealth Management’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$36K	Hold	300	–	–	﹤0.01%	376
2023 Q1	$46K	Hold	300	–	–	0.01%	355
2022 Q4	$54K	Hold	300	–	–	0.01%	319
2022 Q3	$35K	Hold	300	–	–	0.01%	361
2022 Q2	$43K	Hold	300	–	–	0.01%	342
2022 Q1	$52K	Sell	300 -150	-33%	-$25.3K	0.01%	344
2021 Q4	$114K	Hold	450	–	–	0.01%	271
2021 Q3	$173K	Hold	450	–	–	0.02%	226
2021 Q2	$105K	Hold	450	–	–	0.01%	281
2021 Q1	$59K	Hold	450	–	–	0.01%	343
2020 Q4	$47K	Hold	450	–	–	0.01%	331
2020 Q3	$32K	Hold	450	–	–	﹤0.01%	352
2020 Q2	$29K	Sell	450 -300	-40%	-$16.4K	﹤0.01%	364
2020 Q1	$22K	Buy	+750	New	+$17.3K	﹤0.01%	356

Other funds holding MRNA

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Endurance Wealth Management's MRNA Position: Q2 2023 in Review

Endurance Wealth Management held its Moderna (MRNA) position steady in Q2 2023 at 300 shares worth $36K. The position accounts for ﹤0.01% of the portfolio, ranked #376.

Endurance Wealth Management first reported a position in MRNA in Q1 2020 and has held it in 14 quarters since. The position peaked at $173K in Q3 2021. 967 funds tracked by Wall St. Rank hold MRNA as of Q2 2023.

Endurance Wealth Management held 300 shares of Moderna worth $36K as of Q2 2023.
Endurance Wealth Management left its Moderna share count unchanged in Q2 2023.
Moderna made up ﹤0.01% of Endurance Wealth Management's portfolio in Q2 2023, its #376 holding.
Endurance Wealth Management first reported a position in Moderna in Q1 2020 and has held it in 14 quarters since.
Endurance Wealth Management's Moderna position peaked at $173K in Q3 2021.
967 funds tracked by Wall St. Rank held Moderna as of Q2 2023.

Based on Endurance Wealth Management's 13F filing for Q2 2023, filed 9 Aug 2023.